Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) EPS (Weighted Average and Diluted): 2011-2025

Historic EPS (Weighted Average and Diluted) for Abeona Therapeutics (ABEO) over the last 7 years, with Sep 2025 value amounting to -$0.10.

  • Abeona Therapeutics' EPS (Weighted Average and Diluted) rose 84.13% to -$0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.23, marking a year-over-year increase of 145.72%. This contributed to the annual value of -$1.55 for FY2024, which is 38.74% up from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' EPS (Weighted Average and Diluted) is -$0.10, which was down 105.85% from $1.71 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at $3.80 for Q2 2022, and its period low was -$1.16 during Q1 2024.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$0.31, with a median of -$0.48 in 2023.
  • Per our database at Business Quant, Abeona Therapeutics' EPS (Weighted Average and Diluted) crashed by 223.08% in 2023 and then soared by 757.69% in 2025.
  • Quarterly analysis of 4 years shows Abeona Therapeutics' EPS (Weighted Average and Diluted) stood at $0.52 in 2022, then tumbled by 223.08% to -$0.64 in 2023, then skyrocketed by 78.12% to -$0.14 in 2024, then soared by 84.13% to -$0.10 in 2025.
  • Its EPS (Weighted Average and Diluted) was -$0.10 in Q3 2025, compared to $1.71 in Q2 2025 and -$0.24 in Q1 2025.